News
Zacks Investment Research on MSN2d
LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III StudyShares of Eli Lilly LLY soared 14.3% on April 17 after data from a late-stage study showed that orforglipron achieved the ...
Investor's Business Daily on MSN6d
Eli Lilly Rockets 14% After Solidifying Its Lead For A Weight-Loss PillEli Lilly stock jetted higher Thursday after the company said its diabetes and weight-loss pill helped patients lose up to 16 pounds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback